Carsten A. Vock

发表

Novel CYP17 inhibitors: synthesis, biological evaluation, structure-activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls.

Ulrike E. Hille, Qingzhong Hu, Carsten A. Vock, 2009, European journal of medicinal chemistry.

Improved Synthesis of the [Ru(η6‐p‐cymene)Cl3] Anion: Facile Isolation under Mild Conditions

Carsten A. Vock, P. Dyson, 2007 .

Synthesis of enantiopure B-nor-steroids by multiple Pd-catalyzed transformations

Carsten A. Vock, L. Tietze, J. Wiegand, 2003 .

Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms.

Andrew D. Phillips, Carsten A. Vock, L. Juillerat-Jeanneret, 2007, Journal of medicinal chemistry.

Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.

Andrew D. Phillips, Carsten A. Vock, R. Scopelliti, 2006, Journal of medicinal chemistry.

Synthesis of Novel StructurallySimplified Estrogen Analogues with Electron-Donating Groups in RingA

Carsten A. Vock, L. Tietze, Ilga K. Krimmelbein, 2009 .

Synthesis of novel structurally simplified estrogen analogues.

Carsten A. Vock, C. Gatz, L. Tietze, 2008, Chemistry.

A new promising application for highly cytotoxic metal compounds: η6-areneruthenium(II) phosphite complexes for the treatment of alveolar echinococcosis.

Carsten A. Vock, M. Kindermann, A. Hemphill, 2012, Journal of medicinal chemistry.

N-(Pyridin-3-yl)benzamides as selective inhibitors of human aldosterone synthase (CYP11B2).

Carsten A. Vock, R. Hartmann, Christina Zimmer, 2011, Bioorganic & medicinal chemistry letters.

Influence of the Diketonato Ligand on the Cytotoxicities of [Ru(η6-p-cymene)(R2acac)(PTA)]+ Complexes (PTA = 1,3,5-triaza-7-phosphaadamantane)

Carsten A. Vock, L. Juillerat-Jeanneret, R. Scopelliti, 2008 .

First Selective CYP11B1 Inhibitors for the Treatment of Cortisol-Dependent Diseases.

Ulrike E. Hille, Carsten A. Vock, R. Hartmann, 2011, ACS medicinal chemistry letters.

Toxoplasma gondii Tachyzoites Complexes in Neospora caninum and Effects of Novel Ruthenium In Vitro

Carsten A. Vock, A. Hemphill, K. Debache, 2014 .

In Vitro Effects of Novel Ruthenium Complexes in Neospora caninum and Toxoplasma gondii Tachyzoites

Carsten A. Vock, A. Hemphill, K. Debache, 2013, Antimicrobial Agents and Chemotherapy.

Synthesis and Crystallographic Characterisation of the Heterodimetallic Complex [(Dibenzo-18-crown-6)K(μ-Cl)3Ru(η6-p-cymene)]

Carsten A. Vock, R. Scopelliti, P. Dyson, 2007 .

Directed evolution of estrogen receptor proteins with altered ligand-binding specificities.

Huimin Zhao, Carsten A. Vock, Huimin Zhao, 2009, Protein engineering, design & selection : PEDS.

Steroidogenic cytochrome P450 (CYP) enzymes as drug targets: Combining substructures of known CYP inhibitors leads to compounds with different inhibitory profile

Ulrike E. Hille, Qingzhong Hu, Carsten A. Vock, 2009 .

In Vitro Effects of Novel Ruthenium Complexes in Neospora caninum and Toxoplasma gondii Tachyzoites

Carsten A. Vock, A. Hemphill, K. Debache, 2013, Antimicrobial Agents and Chemotherapy.

Novel CYP17 inhibitors: synthesis, biological evaluation, structure-activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls.

Ulrike E. Hille, Qingzhong Hu, Carsten A. Vock, 2009, European journal of medicinal chemistry.